Cromos Pharma
Business Services · Texas, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Preston Commons Center 8117 Preston Rd S...Phone Number
(484) 473-1479Website
www.cromospharma.comRevenue
$42.4 MillionIndustry
About Cromos Pharma
Cromos Pharma Org Chart
Is Cromos Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Cromos Pharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Cromos Pharma had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Cromos Pharma
Product Launch: Get notified when Cromos Pharma launches new products
Cromos Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Cromos Pharma has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Cromos Pharma has new funding data
Earning: See what the market has to say on Cromos Pharma recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Cromos Pharma
Find 3 more new buyers
Compare Similar Companies to Cromos Pharma
Compare insights from companies similar to Cromos Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cromos Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cromos Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cromos Pharma.
Cromos Pharma Tech Stack
A closer look at the technologies used by Cromos Pharma
Most Recent Scoops
Cromos Pharma News & Media
Pioneering Cancer Treatment: the Successful Partnership Between MAIA Biotechnology and Cromos Pharma
MAIA Biotechnology, a leader in targeted therapy and immuno-oncology, partnered with Cromos Pharma, an international CRO, to advance cancer treatment. At ASCO 2024, MAIA unveiled promising interim data for THIO, a telomere-targeting agent for NSCLC, showing an 85% disease control rate with THIO and Libtayo in advanced patients. Cromos excelled in patient recruitment and regulatory approvals in key European countries. This [PR.com]Sapu BioScience and Cromos Pharma initiating P201 – A Registrational trial for OT-101 in Pancreatic Cancer
AGOURA HILLS, Calif., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), announced today its joint venture partner, GMP Biotechnology Limited’s wholly owned subsidiary – Sapu Bioscience, LLC (“Sapu”), together with with Cromos Pharma, LLC (“Cromos”), a US-based international contract research organization (“CRO”), to conduct Sapu’s registrational trial for OT-101 in Pancreatic Cancer.Cromos Pharma, A US-Based, International CRO, Solidifies Its Operational Presence in Türkiye, Kazakhstan and Serbia
Cromos Pharma has opened permanent offices in Turkiye, Kazakhstan and Serbia. The Serbian office will serve as a hub in the Balkans. PORTLAND, OR, UNITED STATES, September 20, 2022 /EINPresswire.com/ -- Cromos Pharma, a US-based international CRO with …International Clinical Research Organization Cromos Pharma Launches FREE FEASIBILITY REPORT Initiative
US-based Clinical Research Organization Cromos Pharma Launches FREE FEASIBILITY REPORT Initiative for sponsors conducting trials in Central & Eastern Europe PORTLAND, OREGON, USA, July 6, 2021 /EINPresswire.com/ -- US-based international clinical …
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cromos Pharma
Cromos Pharma is a US-based, international contract research organization delivering fully integrated clinical research solutions, in all trial phases, across a wide range of therapeutic indications. Their expert team, comprised of 95% MDs, has extensive expertise in study design, medical writing, regulatory affairs, site management, patient recrui... Read More